Humira Drug Market Growth Outlook Through 2024-2033

Overview and Scope
Humira drug, or adalimumab, refers to an injection prescribed to treat rheumatoid arthritis and other conditions. These drugs are used to reduce the pain and swelling caused by several types of arthritis.

Sizing and Forecast
The humira drug market size has grown strongly in recent years. It will grow from $9.19 billion in 2023 to $9.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to introduction of biologics, biotechnology advancements, patient demand for effective treatments, physician adoption and prescribing patterns.

The humira drug market size is expected to see strong growth in the next few years. It will grow to $13.05 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to biosimilar market entry, healthcare policy changes, focus on cost-effectiveness, research and development investments, precision medicine and personalized treatments. Major trends in the forecast period include real-world evidence generation, expanded use in pediatric populations, shift towards self-administered medications, value-based pricing models, targeted therapies development.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

Segmentation & Regional Insights
The humira drug market covered in this report is segmented –

1) By Type: Humira Syringe, Humira Pen
2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease, Other Applications
3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

North America was the largest region in the humira drug market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=11934&type=smp

Major Driver Impacting Market Growth
A rise in the incidence rate of autoimmune disease is expected to propel the growth of the humira drug market going forward. Autoimmune disease refers to a type of disease in which the body’s immune system attacks and destroys healthy tissues and cells in the body. Humira drug is used to treat pain and inflammation caused by various autoimmune diseases, as a result, the rise in the incidence rate of autoimmune diseases increases the demand for humira drug. For instance, in July 2021, according to Cleveland Clinics, a US-based non-profit academic medical center, 1 in 15 people in the U.S. have an autoimmune disease. Further, one million people in the U.S. are suffering from lupus and 1.4 million have Crohn’™s disease or ulcerative colitis respectively. Therefore, the rise in the incidence rate of autoimmune disease will drive the HUMIRA drug market.

Key Industry Players

Major companies operating in the humira drug market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

The humira drug market report table of contents includes:

1. Executive Summary
2. Humira Drug Market Characteristics
3. Humira Drug Market Trends And Strategies
4. Humira Drug Market – Macro Economic Scenario
5. Global Humira Drug Market Size and Growth
.
.
.
31. Humira Drug Market Other Major And Innovative Companies
32. Global Humira Drug Market Competitive Benchmarking
33. Global Humira Drug Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Humira Drug Market
35. Humira Drug Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model